Paper Title:
Surface Modification of Magnetite Nanoparticles with Doxorubicin and RGD Peptide and their Biomedical Application
  Abstract

In the present study, superparamagnetic maltotrionic acid-coated magnetite nanoparticles (MAM) were surface modified with doxorubicin (DOX) and RGD peptide to improve their intracellular uptake, ability to target tumor cells and antitumer effect. RGD was added to the distal end of MAM aiming to construct an enhanced tumor targeting delivery system. To test its targeting effect, DOX, a widely used anticancer drug, was immobilized on the RGD-modified magnetite nanoparticles. DOX-coated magnetite nanoparticles were also prepared as a control. KB cell culture experiment showed that both DOX-modified nanoparticles and DOX-RGD peptide-modified magnetite nanoparticles (DRMAM) were internalized into the cells. But the uptake amount of DRMAMs was higher than that of DOX-modified nanoparticles. This result indicates that DRMAMs have a great potential to be used as contrast agent and antitumor medicine.

  Info
Periodical
Key Engineering Materials (Volumes 342-343)
Edited by
Young-Ha Kim, Chong-Su Cho, Inn-Kyu Kang, Suk Young Kim and Oh Hyeong Kwon
Pages
793-796
DOI
10.4028/www.scientific.net/KEM.342-343.793
Citation
K.M. Kamruzzaman Selim, M. J. Park, H. M. Kim, I. K. Kang, "Surface Modification of Magnetite Nanoparticles with Doxorubicin and RGD Peptide and their Biomedical Application", Key Engineering Materials, Vols. 342-343, pp. 793-796, 2007
Online since
July 2007
Export
Price
$32.00
Share

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: Yue Qing Shen, Meng Lu Pu, Wei Jiang
Chapter 8: Biomaterials, Biotechnologies and Pharmaceutics
Abstract:Efficient delivery of drug to tumor cells is one of the crucial issues in cancer therapy. This letter addresses for the first time that poly...
723